2,4-Hexadienol monopropionate
Common Name: |
2,4-Hexadienol monopropionate |
IUPAC Name: |
[(2Z,4E)-hexa-2,4-dienyl] propanoate |
Molecular Formula: |
C9H14O2 |
SMILES: |
CCC(=O)OCC=CC=CC |
Inchi: |
1S/C9H14O2/c1-3-5-6-7-8-11-9(10)4-2/h3,5-7H,4,8H2,1-2H3/b5-3+,7-6- |
Inchi Key: |
ZVBREIRNEOXCKQ-WZWXSLMZSA-N |
Cas No: |
16491-25-1 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
154.21 |
Mass (g/mol) |
154.099 |
Molar Refractivity |
45.71 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
5 |
Rings |
|
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
75.00 @ 15.00 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
0.223 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.44 |
LogP |
2.072 |
iLOGP |
2.72 |
XLOGP3 |
2.11 |
WLOGP |
2.07 |
MLOGP |
2.07 |
ESOL Log S |
-1.80 |
ESOL Solubility (mg/ml) |
2.47 |
ESOL Solubility (mol/l) |
0.016 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-2.29 |
Ali Solubility (mg/ml) |
0.79 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.32 |
Silicos-IT Solubility (mg/ml) |
7.43 |
Silicos-IT Solubility (mol/l) |
0.05 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.74 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.716 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.475 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |